<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=854972431912402&amp;ev=PageView&amp;noscript=1">

Followed By
A Live Moderated Q&A Panel Discussion took place on Thursday, February 11th



While the live event is over, we have extended access to Psychedelia, a 60-minute documentary about psychedelic drugs and their ability to induce mystical experiences until Monday, February 15th at 3:00 PM PT / 6:00 PM ET / 11:00 PM GMT / 12:00 AM CET.

This engaging film chronicles the scientific research studies prior to the cultural upheaval of the 1960s, when LSD was regarded as a promising medical breakthrough, to the present-day research in psychiatry, where leading experts in the field of psychedelic research have re-introduced these compounds into a legal and growing field of study. 

Featuring leading experts in the field, the film takes viewers on a journey through the origins and resurgence of psychedelic research and explores the profound effects these mind-altering compounds have had on spirituality and culture throughout the ages. With first-person accounts from patients with end-of-life anxiety, this work explores the profound and life-altering insights psychedelics induce in participants, and the potential impact psychedelics hold for humanity.


After the screening, there will be a 60-minute moderated panel discussion including an opportunity for Q&A.


Q&A Panelists

Pat Murphy
Psychedelia film director
John Glazer
Jonathan Glazer
Co-founder, ThankYouPlantMedicine
Andrea Jungaberle
MD, Co-founder and Director of Collaboration and Media, MIND Foundation
Jakobien (2)
Jakobien van der Weijden
Director of Customer Support at Synthesis and Co-Founder of Microdosing Institute


There’s no cost to access the film. Simply register by completing the registration form below to receive instructions.

Donations will be welcomed are welcome and if you feel called to support the progress being made in psychedelic education, all donation proceeds will go to SafeJourney Portugal and Psychedelia.